Skip to main content
Have a personal or library account? Click to login
Outcomes of Medulloblastoma Treated with Volumetric Modulated Arc Therapy Craniospinal Irradiation: A Retrospective Study Cover

Outcomes of Medulloblastoma Treated with Volumetric Modulated Arc Therapy Craniospinal Irradiation: A Retrospective Study

Open Access
|Apr 2026

References

  1. Gajjar A, Chintagumpala M, Ashley D, Kellie S, Kun LE, Merchant TE, et al. Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): Long-term results from a prospective, multicentre trial. Lancet Oncol. 2006;7(10):813–20. doi:10.1016/S1470-2045(06)70867-1.
  2. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, et al. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. J Clin Oncol. 2006;24(25):4202–8. doi:10.1200/JCO.2006.06.4980.
  3. Pizer BL, Weston CL, Robinson KJ, Ellison DW, Ironside J, Saran F, et al. Analysis of patients with supratentorial primitive neuroectodermal tumours in the SIOP/UKCCSG PNET3 study. Eur J Cancer. 2006;42(8):1120–8. doi:10.1016/j.ejca.2006.01.062.
  4. Holupka EJ, Humm JL, Tarbell NJ, Svensson GK. Effect of setup error on the dose across the junction of matching cranial-spinal fields. Int J Radiat Oncol Biol Phys. 1993;27(2):345–52. doi:10.1016/0360-3016(93)90230-2.
  5. Jefferies S, Rajan B, Ashley S, Traish D, Brada M. Haematological toxicity of cranio-spinal irradiation. Radiother Oncol. 1998;48(1):23–7. doi:10.1016/S0167-8140(98)00047-3.
  6. Ziemann C, Cremers F, Motisi L, Gaertig L, Guhlich M, Niehaus K, et al. Novel hybrid treatment planning for pediatric craniospinal axis irradiation. Med Dosim. 2024;49:93–101. doi:10.1016/j.meddos.2023.08.011.
  7. Li S, Wu Z, Lu J, Yu X, Fang H, Tang G, et al. Modified two-isocenter VMAT technique for craniospinal irradiation in pediatric patients. J Appl Clin Med Phys. 2022;23(5):e13580. doi:10.1002/acm2.13580.
  8. Nigerian VMAT CSI study. Radiother Oncol. 2023;184:109598.
  9. Simiele E, Romero IO, Wang JY, Chen Y, Lozko Y, Severyn Y, et al. Automated contouring, treatment planning, and quality assurance for VMAT craniospinal irradiation (VMAT-CSI). Front Oncol. 2024;14:1378449. doi:10.3389/fonc.2024.1378449.
  10. Packer RJ, Gajjar A, Vezina G, et al. Craniospinal irradiation followed by chemotherapy: Phase III trial. J Clin Oncol. 2006;24(25):4202–8. doi:10.1200/JCO.2006.06.4980.
  11. Michalski JM, Janss AJ, Vezina G, Packer RJ, et al. Phase III trial of low-dose craniospinal irradiation with chemotherapy for average-risk medulloblastoma. Int J Radiat Oncol Biol Phys. 2016;96(3):937–8. doi:10.1016/j.ijrobp.2016.08.023.
  12. Nguyen QN, Chang EL, Allen PK, Mahajan A, Woo SY. Benefits of VMAT in craniospinal irradiation. Radiother Oncol. 2022;171: 105–12. doi:10.1016/j.radonc.2022.08.014.
  13. Chen Y, Yang J, Lu W, Chen J, Zhu J, Xie C, et al. Dosimetric comparison of VMAT and proton therapy for craniospinal irradiation. Int J Radiat Oncol Biol Phys. 2012;82(2):635–41. doi:10.1016/j.ijrobp.2010.12.066.
  14. Sharma DS, Gupta T, Jalali R, Master Z, Phurailatpam RD, Sarin R. High-precision radiotherapy for craniospinal irradiation: Evaluation of three-dimensional conformal, intensity-modulated and helical tomotherapy techniques. Br J Radiol. 2009;82(984):1000–9. doi:10.1259/bjr/88256274.
  15. Shoa P, Rahimian J, Jalali R, et al. Visual system complication estimation after craniospinal irradiation. Int J Radiat Res. 2020;18(1):117–23.
  16. Faber J, Wingerter A, Neu MA, Hennewig U, Bender HU, Blettner M, et al. Cardiovascular late effects in childhood cancer survivors: The German CVSS study. Eur Heart J. 2018;39(17):1555–62. doi:10.1093/eurheartj/ehx747.
  17. Braunstein S, Nakamura JL. Radiotherapy-induced malignancies: Review and clinical implications. Front Oncol. 2013;3:73. doi:10.3389/fonc.2013.00073.
Language: English
Page range: 40 - 45
Published on: Apr 3, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2026 Muhammad Anas Tahseen Asar, Tabinda Sadaf, Asma Rashid, Aqueel Shahid, Fajar Rafi Ranjha, Raheel Mukhtar, Haniya Rizwan, Ahmad Rashid, published by Shakuat Khanum Memorial Cancer Hospital and Research Centre
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.